Partially offsetting this are declines in cardiovascular drug Xarelto due to loss of exclusivity events across various territories, which is putting pressure on both revenue growth and profit margins.

In the U.S., six non-steroidal anti-inflammatory drugs (NSAIDs) are most commonly used to manage pain and inflammation. While ...

In partnership with Liveo Research, Bayer has developed a 'first-of-its-kind' PET blister pack for its over-the-counter Aleve drug brand - and reports a 38% reduction in carbon footprint through its ...

“Orlynvah has the potential to be an important treatment option for those who need it,” she said in a news release from Iterum Therapeutics, the drug’s maker. The FDA approved Orlynvah based ...

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Federal officials have celebrated a striking drop in drug overdoses across the country. But state-level data shows that Black people are suffering significantly worse outcomes than white people.

In its latest guidance, released Wednesday, the CDC recommends that adults aged 65 and older, as well as individuals with weakened immune systems, receive a second dose of the updated vaccine six ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) officially recommended.

The drug Donanemab has been found to slow the progression of Alzheimer’s disease. Despite this is has been rejected for widespread use in the health service in England after the health spending ...

On X recently, Eric Topol, a cardiologist who leads Scripps Research, a non-profit research institute in San Diego, California, called GLP-1 drugs “the most important drug-class breakthrough in ...

A pioneering new drug, which has been shown to slow the advance of Alzheimer's, will not be available to patients on the NHS as Ian Woods reports. A new "effective" Alzheimer's drug has been ...

For many patients on tirzepatide, a transformative medication used for weight loss and diabetes, the end of the drug's shortage was anything but welcome news. "I had an anxiety attack," said Maria ...